Fredun Pharmaceuticals Ltd — Important, 11-10-2025: Company Update

Fredun Pharmaceuticals has confirmed its adherence to investor protection rules for the quarter ending September 30, 2025. The company's Registrar and Share Transfer Agent verified that all physical share certificates received for dematerialisation were processed accurately and within set timelines. This includes confirming acceptance or rejection to depositories, ensuring shares are listed, and properly cancelling physical certificates. This update signifies sound operational practices in managing shareholder records and facilitating electronic share transfers, which is crucial for maintaining market integrity and investor confidence.